Bill

Bill > S1548


US S1548

ENACT Act of 2021 Equity in Neuroscience and Alzheimer’s Clinical Trials Act of 2021


summary

Introduced
05/11/2021
In Committee
05/11/2021
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To amend the Public Health Service Act to improve the diversity of participants in research on Alzheimer’s dis- ease, and for other purposes.

AI Summary

This bill, the Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 (ENACT Act of 2021), aims to improve the diversity of participants in research on Alzheimer's disease. The key provisions of the bill include: expanding access to Alzheimer's research centers in areas with higher concentrations of minority groups; providing outreach and education efforts to increase awareness and participation of minority groups in Alzheimer's clinical trials; offering incentives and training to encourage principal investigators and researchers from underrepresented populations to participate in Alzheimer's research; and modifying clinical trial eligibility criteria to better reflect the diversity of the patient population. The bill also authorizes $60 million in funding per year from 2022 to 2026 to implement these changes.

Committee Categories

Health and Social Services

Sponsors (19)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 05/11/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...